Smoore International Holdings Limited
Smoore International Holdings Limited (SMORF) Stock Competitors & Peer Comparison
See (SMORF) competitors and their performances in Stock Market.
Peer Comparison Table: Tobacco Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| SMORF | $1.40 | +0.00% | 8.7B | 46.67 | $0.03 | +2.29% |
| BTAFF | $68.61 | +5.12% | 148.4B | 14.75 | $4.65 | +4.75% |
| JAPAY | $20.01 | -0.79% | 71.2B | 22.52 | $0.89 | +3.43% |
| JAPAF | $39.99 | +3.49% | 71B | 22.60 | $1.77 | +3.88% |
| IMBBY | $38.58 | -0.18% | 29.9B | 13.69 | $2.83 | +5.55% |
| IMBBF | $37.70 | +0.37% | 29.3B | 13.38 | $2.83 | +5.69% |
| SWMAY | $10.57 | +0.00% | 16.1B | 27.82 | $0.38 | N/A |
| PHJMF | $0.05 | +0.00% | 5.8B | 5.00 | $0.01 | +7.00% |
| GGNPF | $0.96 | +0.00% | 1.8B | 32.00 | $0.03 | +3.20% |
| GDNGY | $3.75 | +0.00% | 1.8B | 10.71 | $0.35 | +3.27% |
Stock Comparison
SMORF vs BTAFF Comparison May 2026
SMORF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMORF stands at 8.7B. In comparison, BTAFF has a market cap of 148.4B. Regarding current trading prices, SMORF is priced at $1.40, while BTAFF trades at $68.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMORF currently has a P/E ratio of 46.67, whereas BTAFF's P/E ratio is 14.75. In terms of profitability, SMORF's ROE is +0.05%, compared to BTAFF's ROE of +0.16%. Regarding short-term risk, SMORF is less volatile compared to BTAFF. This indicates potentially lower risk in terms of short-term price fluctuations for SMORF.Check BTAFF's competition here
SMORF vs JAPAY Comparison May 2026
SMORF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMORF stands at 8.7B. In comparison, JAPAY has a market cap of 71.2B. Regarding current trading prices, SMORF is priced at $1.40, while JAPAY trades at $20.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMORF currently has a P/E ratio of 46.67, whereas JAPAY's P/E ratio is 22.52. In terms of profitability, SMORF's ROE is +0.05%, compared to JAPAY's ROE of +0.14%. Regarding short-term risk, SMORF is less volatile compared to JAPAY. This indicates potentially lower risk in terms of short-term price fluctuations for SMORF.Check JAPAY's competition here
SMORF vs JAPAF Comparison May 2026
SMORF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMORF stands at 8.7B. In comparison, JAPAF has a market cap of 71B. Regarding current trading prices, SMORF is priced at $1.40, while JAPAF trades at $39.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMORF currently has a P/E ratio of 46.67, whereas JAPAF's P/E ratio is 22.60. In terms of profitability, SMORF's ROE is +0.05%, compared to JAPAF's ROE of +0.13%. Regarding short-term risk, SMORF and JAPAF have similar daily volatility (0.00).Check JAPAF's competition here
SMORF vs IMBBY Comparison May 2026
SMORF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMORF stands at 8.7B. In comparison, IMBBY has a market cap of 29.9B. Regarding current trading prices, SMORF is priced at $1.40, while IMBBY trades at $38.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMORF currently has a P/E ratio of 46.67, whereas IMBBY's P/E ratio is 13.69. In terms of profitability, SMORF's ROE is +0.05%, compared to IMBBY's ROE of +0.39%. Regarding short-term risk, SMORF is less volatile compared to IMBBY. This indicates potentially lower risk in terms of short-term price fluctuations for SMORF.Check IMBBY's competition here
SMORF vs IMBBF Comparison May 2026
SMORF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMORF stands at 8.7B. In comparison, IMBBF has a market cap of 29.3B. Regarding current trading prices, SMORF is priced at $1.40, while IMBBF trades at $37.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMORF currently has a P/E ratio of 46.67, whereas IMBBF's P/E ratio is 13.38. In terms of profitability, SMORF's ROE is +0.05%, compared to IMBBF's ROE of +0.39%. Regarding short-term risk, SMORF is less volatile compared to IMBBF. This indicates potentially lower risk in terms of short-term price fluctuations for SMORF.Check IMBBF's competition here
SMORF vs SWMAY Comparison May 2026
SMORF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMORF stands at 8.7B. In comparison, SWMAY has a market cap of 16.1B. Regarding current trading prices, SMORF is priced at $1.40, while SWMAY trades at $10.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMORF currently has a P/E ratio of 46.67, whereas SWMAY's P/E ratio is 27.82. In terms of profitability, SMORF's ROE is +0.05%, compared to SWMAY's ROE of N/A. Regarding short-term risk, SMORF and SWMAY have similar daily volatility (0.00).Check SWMAY's competition here
SMORF vs PHJMF Comparison May 2026
SMORF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMORF stands at 8.7B. In comparison, PHJMF has a market cap of 5.8B. Regarding current trading prices, SMORF is priced at $1.40, while PHJMF trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMORF currently has a P/E ratio of 46.67, whereas PHJMF's P/E ratio is 5.00. In terms of profitability, SMORF's ROE is +0.05%, compared to PHJMF's ROE of +0.25%. Regarding short-term risk, SMORF is less volatile compared to PHJMF. This indicates potentially lower risk in terms of short-term price fluctuations for SMORF.Check PHJMF's competition here
SMORF vs GGNPF Comparison May 2026
SMORF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMORF stands at 8.7B. In comparison, GGNPF has a market cap of 1.8B. Regarding current trading prices, SMORF is priced at $1.40, while GGNPF trades at $0.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMORF currently has a P/E ratio of 46.67, whereas GGNPF's P/E ratio is 32.00. In terms of profitability, SMORF's ROE is +0.05%, compared to GGNPF's ROE of +0.05%. Regarding short-term risk, SMORF and GGNPF have similar daily volatility (0.00).Check GGNPF's competition here
SMORF vs GDNGY Comparison May 2026
SMORF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMORF stands at 8.7B. In comparison, GDNGY has a market cap of 1.8B. Regarding current trading prices, SMORF is priced at $1.40, while GDNGY trades at $3.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMORF currently has a P/E ratio of 46.67, whereas GDNGY's P/E ratio is 10.71. In terms of profitability, SMORF's ROE is +0.05%, compared to GDNGY's ROE of +0.05%. Regarding short-term risk, SMORF is less volatile compared to GDNGY. This indicates potentially lower risk in terms of short-term price fluctuations for SMORF.Check GDNGY's competition here
SMORF vs PHPMF Comparison May 2026
SMORF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMORF stands at 8.7B. In comparison, PHPMF has a market cap of 1.7B. Regarding current trading prices, SMORF is priced at $1.40, while PHPMF trades at $910.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMORF currently has a P/E ratio of 46.67, whereas PHPMF's P/E ratio is 17.12. In terms of profitability, SMORF's ROE is +0.05%, compared to PHPMF's ROE of +0.41%. Regarding short-term risk, SMORF is less volatile compared to PHPMF. This indicates potentially lower risk in terms of short-term price fluctuations for SMORF.Check PHPMF's competition here
SMORF vs SNDVF Comparison May 2026
SMORF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMORF stands at 8.7B. In comparison, SNDVF has a market cap of 878.4M. Regarding current trading prices, SMORF is priced at $1.40, while SNDVF trades at $11.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMORF currently has a P/E ratio of 46.67, whereas SNDVF's P/E ratio is 8.45. In terms of profitability, SMORF's ROE is +0.05%, compared to SNDVF's ROE of +0.08%. Regarding short-term risk, SMORF is less volatile compared to SNDVF. This indicates potentially lower risk in terms of short-term price fluctuations for SMORF.Check SNDVF's competition here
SMORF vs STBGY Comparison May 2026
SMORF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMORF stands at 8.7B. In comparison, STBGY has a market cap of 855M. Regarding current trading prices, SMORF is priced at $1.40, while STBGY trades at $5.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMORF currently has a P/E ratio of 46.67, whereas STBGY's P/E ratio is 8.23. In terms of profitability, SMORF's ROE is +0.05%, compared to STBGY's ROE of +0.08%. Regarding short-term risk, SMORF and STBGY have similar daily volatility (0.00).Check STBGY's competition here
SMORF vs KCIGF Comparison May 2026
SMORF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMORF stands at 8.7B. In comparison, KCIGF has a market cap of 828M. Regarding current trading prices, SMORF is priced at $1.40, while KCIGF trades at $300.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMORF currently has a P/E ratio of 46.67, whereas KCIGF's P/E ratio is 8.83. In terms of profitability, SMORF's ROE is +0.05%, compared to KCIGF's ROE of +0.14%. Regarding short-term risk, SMORF and KCIGF have similar daily volatility (0.00).Check KCIGF's competition here
SMORF vs CHUC Comparison May 2026
SMORF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMORF stands at 8.7B. In comparison, CHUC has a market cap of 75.8M. Regarding current trading prices, SMORF is priced at $1.40, while CHUC trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMORF currently has a P/E ratio of 46.67, whereas CHUC's P/E ratio is 13.82. In terms of profitability, SMORF's ROE is +0.05%, compared to CHUC's ROE of +2.98%. Regarding short-term risk, SMORF is less volatile compared to CHUC. This indicates potentially lower risk in terms of short-term price fluctuations for SMORF.Check CHUC's competition here
SMORF vs PYYX Comparison May 2026
SMORF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMORF stands at 8.7B. In comparison, PYYX has a market cap of 59.3M. Regarding current trading prices, SMORF is priced at $1.40, while PYYX trades at $2.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMORF currently has a P/E ratio of 46.67, whereas PYYX's P/E ratio is -12.68. In terms of profitability, SMORF's ROE is +0.05%, compared to PYYX's ROE of -0.03%. Regarding short-term risk, SMORF is less volatile compared to PYYX. This indicates potentially lower risk in terms of short-term price fluctuations for SMORF.Check PYYX's competition here
SMORF vs GGII Comparison May 2026
SMORF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMORF stands at 8.7B. In comparison, GGII has a market cap of 6.7M. Regarding current trading prices, SMORF is priced at $1.40, while GGII trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMORF currently has a P/E ratio of 46.67, whereas GGII's P/E ratio is N/A. In terms of profitability, SMORF's ROE is +0.05%, compared to GGII's ROE of -0.26%. Regarding short-term risk, SMORF and GGII have similar daily volatility (0.00).Check GGII's competition here
SMORF vs WSRRF Comparison May 2026
SMORF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMORF stands at 8.7B. In comparison, WSRRF has a market cap of 6.2M. Regarding current trading prices, SMORF is priced at $1.40, while WSRRF trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMORF currently has a P/E ratio of 46.67, whereas WSRRF's P/E ratio is -5.31. In terms of profitability, SMORF's ROE is +0.05%, compared to WSRRF's ROE of +0.54%. Regarding short-term risk, SMORF is less volatile compared to WSRRF. This indicates potentially lower risk in terms of short-term price fluctuations for SMORF.Check WSRRF's competition here
SMORF vs VPRB Comparison May 2026
SMORF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMORF stands at 8.7B. In comparison, VPRB has a market cap of 3.2M. Regarding current trading prices, SMORF is priced at $1.40, while VPRB trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMORF currently has a P/E ratio of 46.67, whereas VPRB's P/E ratio is -3.50. In terms of profitability, SMORF's ROE is +0.05%, compared to VPRB's ROE of +11.70%. Regarding short-term risk, SMORF is less volatile compared to VPRB. This indicates potentially lower risk in terms of short-term price fluctuations for SMORF.Check VPRB's competition here
SMORF vs VAPR Comparison May 2026
SMORF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMORF stands at 8.7B. In comparison, VAPR has a market cap of 2.2M. Regarding current trading prices, SMORF is priced at $1.40, while VAPR trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMORF currently has a P/E ratio of 46.67, whereas VAPR's P/E ratio is N/A. In terms of profitability, SMORF's ROE is +0.05%, compared to VAPR's ROE of +0.87%. Regarding short-term risk, SMORF is less volatile compared to VAPR. This indicates potentially lower risk in terms of short-term price fluctuations for SMORF.Check VAPR's competition here
SMORF vs LBRG Comparison May 2026
SMORF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMORF stands at 8.7B. In comparison, LBRG has a market cap of 2M. Regarding current trading prices, SMORF is priced at $1.40, while LBRG trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMORF currently has a P/E ratio of 46.67, whereas LBRG's P/E ratio is N/A. In terms of profitability, SMORF's ROE is +0.05%, compared to LBRG's ROE of +0.16%. Regarding short-term risk, SMORF is less volatile compared to LBRG. This indicates potentially lower risk in terms of short-term price fluctuations for SMORF.Check LBRG's competition here
SMORF vs HUMBF Comparison May 2026
SMORF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMORF stands at 8.7B. In comparison, HUMBF has a market cap of 521.6K. Regarding current trading prices, SMORF is priced at $1.40, while HUMBF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMORF currently has a P/E ratio of 46.67, whereas HUMBF's P/E ratio is -0.04. In terms of profitability, SMORF's ROE is +0.05%, compared to HUMBF's ROE of -1.03%. Regarding short-term risk, SMORF and HUMBF have similar daily volatility (0.00).Check HUMBF's competition here
SMORF vs GRLF Comparison May 2026
SMORF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMORF stands at 8.7B. In comparison, GRLF has a market cap of 300.6K. Regarding current trading prices, SMORF is priced at $1.40, while GRLF trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMORF currently has a P/E ratio of 46.67, whereas GRLF's P/E ratio is N/A. In terms of profitability, SMORF's ROE is +0.05%, compared to GRLF's ROE of -0.17%. Regarding short-term risk, SMORF is less volatile compared to GRLF. This indicates potentially lower risk in terms of short-term price fluctuations for SMORF.Check GRLF's competition here
SMORF vs VPOR Comparison May 2026
SMORF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMORF stands at 8.7B. In comparison, VPOR has a market cap of 273K. Regarding current trading prices, SMORF is priced at $1.40, while VPOR trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMORF currently has a P/E ratio of 46.67, whereas VPOR's P/E ratio is N/A. In terms of profitability, SMORF's ROE is +0.05%, compared to VPOR's ROE of +0.94%. Regarding short-term risk, SMORF is less volatile compared to VPOR. This indicates potentially lower risk in terms of short-term price fluctuations for SMORF.Check VPOR's competition here
SMORF vs CBDW Comparison May 2026
SMORF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMORF stands at 8.7B. In comparison, CBDW has a market cap of 262.4K. Regarding current trading prices, SMORF is priced at $1.40, while CBDW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMORF currently has a P/E ratio of 46.67, whereas CBDW's P/E ratio is -0.09. In terms of profitability, SMORF's ROE is +0.05%, compared to CBDW's ROE of +0.68%. Regarding short-term risk, SMORF is less volatile compared to CBDW. This indicates potentially lower risk in terms of short-term price fluctuations for SMORF.Check CBDW's competition here
SMORF vs MEDH Comparison May 2026
SMORF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMORF stands at 8.7B. In comparison, MEDH has a market cap of 157.2K. Regarding current trading prices, SMORF is priced at $1.40, while MEDH trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMORF currently has a P/E ratio of 46.67, whereas MEDH's P/E ratio is -0.05. In terms of profitability, SMORF's ROE is +0.05%, compared to MEDH's ROE of +0.05%. Regarding short-term risk, SMORF and MEDH have similar daily volatility (0.00).Check MEDH's competition here
SMORF vs IDLSF Comparison May 2026
SMORF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMORF stands at 8.7B. In comparison, IDLSF has a market cap of 80.1K. Regarding current trading prices, SMORF is priced at $1.40, while IDLSF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMORF currently has a P/E ratio of 46.67, whereas IDLSF's P/E ratio is N/A. In terms of profitability, SMORF's ROE is +0.05%, compared to IDLSF's ROE of N/A. Regarding short-term risk, SMORF and IDLSF have similar daily volatility (0.00).Check IDLSF's competition here
SMORF vs TOBAF Comparison May 2026
SMORF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMORF stands at 8.7B. In comparison, TOBAF has a market cap of 60K. Regarding current trading prices, SMORF is priced at $1.40, while TOBAF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMORF currently has a P/E ratio of 46.67, whereas TOBAF's P/E ratio is -0.02. In terms of profitability, SMORF's ROE is +0.05%, compared to TOBAF's ROE of -2.56%. Regarding short-term risk, SMORF is less volatile compared to TOBAF. This indicates potentially lower risk in terms of short-term price fluctuations for SMORF.Check TOBAF's competition here
SMORF vs ASHI Comparison May 2026
SMORF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMORF stands at 8.7B. In comparison, ASHI has a market cap of 5.2K. Regarding current trading prices, SMORF is priced at $1.40, while ASHI trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMORF currently has a P/E ratio of 46.67, whereas ASHI's P/E ratio is -0.37. In terms of profitability, SMORF's ROE is +0.05%, compared to ASHI's ROE of +0.12%. Regarding short-term risk, SMORF and ASHI have similar daily volatility (0.00).Check ASHI's competition here
SMORF vs GRAM Comparison May 2026
SMORF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMORF stands at 8.7B. In comparison, GRAM has a market cap of 2.9K. Regarding current trading prices, SMORF is priced at $1.40, while GRAM trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMORF currently has a P/E ratio of 46.67, whereas GRAM's P/E ratio is N/A. In terms of profitability, SMORF's ROE is +0.05%, compared to GRAM's ROE of +2.74%. Regarding short-term risk, SMORF is less volatile compared to GRAM. This indicates potentially lower risk in terms of short-term price fluctuations for SMORF.Check GRAM's competition here
SMORF vs SWMAF Comparison May 2026
SMORF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMORF stands at 8.7B. In comparison, SWMAF has a market cap of 0. Regarding current trading prices, SMORF is priced at $1.40, while SWMAF trades at $10.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMORF currently has a P/E ratio of 46.67, whereas SWMAF's P/E ratio is N/A. In terms of profitability, SMORF's ROE is +0.05%, compared to SWMAF's ROE of N/A. Regarding short-term risk, SMORF and SWMAF have similar daily volatility (0.00).Check SWMAF's competition here